GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.GSK620 is highly selective for the BET-BD2 family of proteins, with >200-fold selectivity over all other bromodomains. GSK620 shows an anti-inflammatory phenotype in human whole blood.
Molecular Weight:
325.36
Purity:
99.05%
CAS Number:
[2088410-46-0]
Formula:
C18H19N3O3
Target:
Epigenetic Reader Domain
T9020
* VAT and and shipping costs not included. Errors and price changes excepted
